Spots Global Cancer Trial Database for nephroureterectomy
Every month we try and update this database with for nephroureterectomy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients | NCT02923557 | Bladder Recurre... Upper Tract Uro... Nephroureterect... | Pirarubicin | 18 Years - | Peking University First Hospital | |
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer | NCT02412670 | High Grade Uppe... | Methotrexate Vinblastine Doxorubicin Cisplatin Gemcitabine Carboplatin Pegfilgrastim Nephroureterect... | 18 Years - | Eastern Cooperative Oncology Group | |
Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer | NCT00696007 | Transitional Ce... | Gemcitabine and... Retrospective c... | 18 Years - | Lahey Clinic | |
Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma | NCT03544437 | Upper Tract Uro... | extraperitoneal... | 15 Years - 80 Years | RenJi Hospital | |
Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary Tract | NCT03474926 | Lymph Node Diss... | Routine Templat... LND only for ly... | 15 Years - 80 Years | RenJi Hospital | |
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer | NCT05775471 | Renal Pelvis an... | Biopsy Biospecimen Col... Enfortumab Vedo... MR Urography Nephroureterect... Pembrolizumab | 18 Years - | Jonsson Comprehensive Cancer Center | |
Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
Translational Cancer Observational Protocol | NCT06169436 | Upper Urinary T... | Nephroureterect... | 18 Years - | IRCCS San Raffaele | |
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma | NCT06262516 | Urothelial Carc... | Nephroureterect... Lymph Node Diss... | 19 Years - | Case Comprehensive Cancer Center | |
Translational Cancer Observational Protocol | NCT06169436 | Upper Urinary T... | Nephroureterect... | 18 Years - | IRCCS San Raffaele | |
Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer | NCT02412670 | High Grade Uppe... | Methotrexate Vinblastine Doxorubicin Cisplatin Gemcitabine Carboplatin Pegfilgrastim Nephroureterect... | 18 Years - | Eastern Cooperative Oncology Group | |
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma | NCT06262516 | Urothelial Carc... | Nephroureterect... Lymph Node Diss... | 19 Years - | Case Comprehensive Cancer Center | |
Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary Tract | NCT03474926 | Lymph Node Diss... | Routine Templat... LND only for ly... | 15 Years - 80 Years | RenJi Hospital | |
Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma | NCT03030157 | Intravesical In... | pirarubicin(THP... | 18 Years - | RenJi Hospital |